HomeVTRS • NASDAQ
Viatris Inc
$9.33
After Hours:
$9.37
(0.38%)+0.035
Closed: Mar 3, 7:11:15 PM GMT-5 · USD · NASDAQ · Disclaimer
Most activeStockUS listed securityUS headquartered
Previous close
$9.23
Day range
$9.27 - $9.69
Year range
$8.77 - $13.50
Market cap
11.14B USD
Avg Volume
11.33M
P/E ratio
-
Dividend yield
5.14%
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD)Dec 2024Y/Y change
Revenue
3.53B-8.06%
Operating expense
1.12B-3.48%
Net income
-516.50M32.54%
Net profit margin
-14.6426.62%
Earnings per share
0.54-13.20%
EBITDA
864.40M-21.99%
Effective tax rate
1.90%
Total assets
Total liabilities
(USD)Dec 2024Y/Y change
Cash and short-term investments
734.80M-37.96%
Total assets
41.50B-12.97%
Total liabilities
22.87B-15.99%
Total equity
18.64B
Shares outstanding
1.19B
Price to book
0.59
Return on assets
1.13%
Return on capital
1.42%
Net change in cash
(USD)Dec 2024Y/Y change
Net income
-516.50M32.54%
Cash from operations
Cash from investing
Cash from financing
Net change in cash
Free cash flow
About
Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020. The name of the corporation comes from the Latin words via, meaning path, and tris, which means three, referring to the path to three main objectives the corporation set: expanding access to medicines, meeting patient needs through innovation, and earning the trust of the healthcare community. Viatris ranked 254th on the 2021 Fortune 500 rankings of the largest United States corporations based on its 2020 total revenue. Wikipedia
Founded
Nov 16, 2020
Employees
32,000
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu